Paul Alebrande, PharmD Candidate

AI is transforming oncology by enhancing clinical trials, personalizing treatments, and improving pharmacy practices, promising faster, more precise cancer care.

Artificial intelligence (AI) is rapidly transforming oncology by enhancing clinical trial design, streamlining patient recruitment, improving precision medicine, and optimizing pharmacy operations, while raising important challenges around data ethics, bias, and integration into clinical workflows.